Dissecting the Structure-Activity Relationship of Galectin-Ligand Interactions

Area of Science:

• Biochemistry
• Molecular Biology
• Pharmacology

Background:

• Galectins are beta-galactoside-binding proteins involved in crucial cellular processes like trafficking, adhesion, and signaling.
• They play significant roles in cancer, inflammation, immune responses, and infections, making them attractive therapeutic targets.

Purpose of the Study:

• To review the development of galectin inhibitors.
• To dissect structure-activity relationships (SAR) for understanding inhibitor-galectin interactions.
• To provide insights for overcoming current challenges in galectin-targeted therapies.

Main Methods:

• Literature review focusing on galectin inhibitor development.
• Analysis of structure-activity relationships.
• Integration of X-ray crystallography and biophysical methods for molecular-level understanding.

Main Results:

• Several galectin inhibitors have been developed, with TD139 in clinical trials for idiopathic pulmonary fibrosis.
• Detailed SAR analysis reveals how inhibitors bind to galectins.
• Combined structural and biophysical data offer deep molecular insights.

Conclusions:

• Galectin inhibitors represent a promising therapeutic strategy for various diseases.
• Understanding SAR is key to designing effective and specific galectin-targeting drugs.
• Further research integrating structural and biophysical data will advance galectin-based therapies.